Fingerprint
Dive into the research topics of 'Phase III, randomized, double-blind, multicenter trial comparing orteronel (TAK-700) plus prednisone with placebo plus prednisone in patients with metastatic castration-resistant prostate cancer that has progressed during or after docetaxel-based therapy: ELM-PC 5'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically